article thumbnail

Excellence Awards 2022 – Winners Announced!

Pharmaceutical Technology

The organisation is a non-profit generic pharmaceutical company and has launched its Insulin Initiative, which aims to drive affordability and accessibility for all Americans, regardless of insurance status. appeared first on Pharmaceutical Technology. Civica JAAQ Sanofi.

Insulin 130
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

It is a dipeptidyl peptidase-4 inhibitor that keeps insulin levels stable and reduces the amount of glucose produced by the body. 5) Toujeo (insulin glargine) Toujeo is very similar to Lantus in that both are insulin glargine, except Toujeo is more concentrated. First approved by the FDA in 2000, NovoRapid generated 15.46

Sales 85